Nurulimab Biosimilar – Anti-CTLA4 mAb – Research Grade

Reference:
Product nameNurulimab Biosimilar - Anti-CTLA4 mAb - Research Grade
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsNurulimab ,BCD-145,CTLA4,anti-CTLA4
ReferencePX-TA1597
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Nurulimab Biosimilar – Anti-CTLA4 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CTLA-4 Protein- Cytotoxic T-lymphocyte protein 4 recombinant protein
Antigen CTLA-4 Protein- Cytotoxic T-lymphocyte protein 4 recombinant protein PX-P4018 210€
Cytotoxic T-lymphocyte protein 4(CTLA4)(Ala37-Asp161)
Antigen Cytotoxic T-lymphocyte protein 4(CTLA4)(Ala37-Asp161) PX-P4782 142€
CD152 / CTLA4, C-His, recombinant protein
Antigen CD152 / CTLA4, C-His, recombinant protein PX-P5569 385€
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control Human IgG1 LALA Isotype Control antibody (HyHEL-10) PTX17885-100 180€
Stable Istotope Labelled Nurulimab  Biosimilar – Anti-CTLA4 mAb – Research Grade
SIL Stable Istotope Labelled Nurulimab Biosimilar – Anti-CTLA4 mAb – Research Grade PX-TA1597-SIL 1500€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.